Prudential plc’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-3,108
Closed -$392K 828
2024
Q2
$392K Hold
3,108
﹤0.01% 650
2024
Q1
$572K Buy
3,108
+374
+14% +$71.2K ﹤0.01% 583
2023
Q4
$492K Sell
2,734
-17
-0.6% -$2.65K 0.01% 777
2023
Q3
$437K Hold
2,751
﹤0.01% 785
2023
Q2
$389K Buy
2,751
+911
+50% +$146K ﹤0.01% 825
2023
Q1
$310K Sell
1,840
-867
-32% -$155K ﹤0.01% 814
2022
Q4
$458K Buy
+2,707
New +$491K 0.01% 784
2021
Q2
Sell
-2,588
Closed -$503K 625
2021
Q1
$503K Sell
2,588
-4,982
-66% -$1.02M ﹤0.01% 524
2020
Q4
$1.45M Sell
7,570
-1,675
-18% -$305K 0.01% 406
2020
Q3
$1.36M Sell
9,245
-3,636
-28% -$520K 0.01% 394
2020
Q2
$1.59M Buy
+12,881
New +$1.52M 0.01% 356

Other funds holding RGEN

Prudential plc's RGEN Position: Q3 2024 in Review

Prudential plc sold out of Repligen (RGEN) in Q3 2024, closing a stake of 3,108 shares — an estimated $392K sold.

Prudential plc first reported a position in RGEN in Q2 2020 and held it in 11 quarters. The position peaked at $1.59M in Q2 2020. 444 funds tracked by Wall St. Rank hold RGEN as of Q3 2024.

  • Prudential plc reported no remaining Repligen position as of Q3 2024 after selling out during the quarter.
  • Prudential plc sold 3,108 Repligen shares in Q3 2024, an estimated $392K.
  • Prudential plc first reported a position in Repligen in Q2 2020 and held it in 11 quarters.
  • Prudential plc's Repligen position peaked at $1.59M in Q2 2020.
  • 444 funds tracked by Wall St. Rank held Repligen as of Q3 2024.

Based on Prudential plc's 13F filing for Q3 2024, filed 13 Nov 2024.